About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Lymphoma Clinical Trials in Illinois | 664 Studies

Clinical Trials LymphomaIllinois

Lymphoma Clinical Trials in Illinois

Find 664 clinical trials for lymphoma near Illinois. Connect with research centers in your area.

All Lymphoma trials nationwide All trials in Illinois

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 221-240 of 664 trials

CompletedStudy of Brexucabtagene Autoleucel (KTE-X19) in Participants With Relapsed/Refractory Mantle Cell Lymphoma (Cohort 3)The goal of this clinical study is to test how well the study drug, brexucabtagene autoleucel (KTE-X19), works in participants with relapsed/refractory (r/r) mantle cell lymphoma…NCT04880434·Gilbert, Arizona and 39 others

Lymphoma Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedEfficacy and Safety Study of Idelalisib in Participants With Indolent B-Cell Non-Hodgkin LymphomasThe primary objective will be to assess the overall response rate and to evaluate the efficacy and safety of idelalisib (IDELA; GS-1101) in participants with previously treated…NCT01282424·Fullerton, California and 40 others

TerminatedStudy of T900607-Sodium in Previously Treated Patients With Non-Hodgkin's Lymphoma.The purpose of the study is to determine whether T900607-sodium is effective and safe in treating non-Hodgkin's lymphoma.NCT00043459·La Jolla, California and 4 others

CompletedDeoxycholic Acid Injection Submental Fat (SMF) Magnetic Resonance Imaging (MRI) and Subject-reported Outcome Measures StudyEvaluation of the safety, tolerability and efficacy of deoxycholic acid injection in the reduction of submental fat (fat below the chin).NCT01032889·Birmingham, Alabama and 9 others

CompletedBlood Stem Cell Transplant With Low Dose Chemotherapy for Relapsed Follicular Non-Hodgkin's Lymphoma (BMT CTN 0701)Blood stem cell transplants are one treatment option for people with lymphoma or other types of blood cancers.NCT00912223·Duarte, California and 20 others

UnknownSafety and Efficacy of p53 Gene Therapy Combined With Immune Checkpoint Inhibitors in Solid Tumors.This is a single arm Phase 2 study of the combination of adenoviral p53 (Ad-p53) gene therapy administered intra-tumorally with approved immune checkpoint inhibitors in patients…NCT03544723·Chicago, Illinois and 2 others

RecruitingA Study of NX-5948 in Adults With Relapsed/Refractory B-cell MalignanciesThis is a first-in-human Phase 1a/1b multicenter, open-label study designed to evaluate the safety and anti-cancer activity of NX-5948 in patients with advanced B-cell…NCT05131022·Duarte, California and 61 others

CompletedStudy of the Safety and Tolerability of PCI-32765 in Patients With Recurrent B Cell LymphomaThe purpose of this study is to establish the safety and optimal dose of orally administered PCI-32765 in patients with recurrent B cell lymphoma.NCT00849654·Palo Alto, California and 8 others

Active not recruitingRollover Study to Provide Continued Treatment for Participants With B-Cell Malignancies Previously Enrolled in Studies of Parsaclisib (INCB050465)This is a Phase 2, multicenter, open-label study to provide continued supply of parsaclisib as monotherapy or in combination therapy with itacitinib, ruxolitinib, or ibrutinib to…NCT04509700·Birmingham, Alabama and 104 others

UnknownRituxan Plus FavId (Idiotype Vaccine) for Low-grade Non-Hodgkin's LymphomaThe purpose of this study is to evaluate the ability of patients treated with Rituxan® plus FavId™ and GM-CSF to mount an immune response (humoral and/or cellular) to KLH and…NCT00041730·La Jolla, California and 14 others

UnknownBAY 59-8862 in Treating Patients With Refractory Non-Hodgkin's LymphomaRATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die.NCT00039156·Miami Beach, Florida and 14 others

CompletedCombination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Previously Untreated HIV-Associated Non-Hodgkin's LymphomaRandomized phase III trial to compare the effectiveness of combination chemotherapy with or without monoclonal antibody therapy in treating patients who have previously untreated…NCT00003595·Los Angeles, California and 12 others

CompletedA Study of ONTAK in Patients With Relapsed or Refractory, B-Cell Non Hodgkin's LymphomaThe goal of this clinical research study is to find out if the study drug, ONTAK (denileukin diftitox), can shrink or slow the growth of B-cell non-Hodgkin's lymphoma (NHL) in…NCT00211276·Beverly Hills, California and 11 others

Not yet recruitingCharacterization of the Microbiome in Cutaneous T Cell Lymphoma Skin Lesions Before and After Use of APR-TD011® (RLF-TD011®) Spray SolutionThis open-label, pilot study will evaluate the tolerance and change in the microbiome from the use of APR-TD011 ((RLF-TD011) wound cleansing spray for the treatment of CTCL skin…NCT05728879·Chicago, Illinois

CompletedObservational Retrospective Cohort Study of Systemic Therapies for R/R DLBCLTo compare the efficacy outcomes of the L-MIND cohort with the effectiveness in a matched patient population treated with systemic NCCN/ESMO guideline listed regimens administered…NCT04697160·Scottsdale, Arizona and 164 others

Active not recruitingA Study of TAK-007 in Adults With Relapsed or Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)This study has 2 parts.NCT05020015·Birmingham, Alabama and 14 others

UnknownCombination Chemotherapy Followed By Vaccine Therapy Plus Sargramostim in Treating Patients With Stage III or Stage IV Non-Hodgkin's LymphomaRATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die.NCT00017290·Dublin, California and 23 others

CompletedImetelstat Sodium in Treating Young Patients With Refractory or Recurrent Solid Tumors or LymphomaRATIONALE: Imetelstat sodium may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.NCT01273090·Birmingham, Alabama and 22 others

CompletedRosiglitazone (Extended Release Tablets) As Adjunctive Therapy In Subjects With Mild To Moderate Alzheimer's DiseaseRosiglitazone (RSG) has been tested in clinical studies and is approved by the FDA as a treatment for type II diabetes mellitus, a disease that occurs when the body is unable to…NCT00348140·Sun City, Arizona and 193 others

CompletedCombination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Older Patients With Non-Hodgkin's LymphomaRATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die.NCT00003150·Mobile, Alabama and 90 others

PreviousPage 12 of 34Next

Other Conditions in Illinois

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia